{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:52:54Z","timestamp":1790031174580,"version":"4.0.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01AI069924"],"award-info":[{"award-number":["U01AI069924"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0205455","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T17:48:22Z","timestamp":1539280102000},"page":"e0205455","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lamivudine monotherapy as a holding regimen for HIV-positive children"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-1367","authenticated-orcid":true,"given":"Gabriela","family":"Patten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bernheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Fairlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobna","family":"Sawry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Technau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Eley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Ann","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for IeDEA Southern Africa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"Virologic failure and second-line antiretroviral therapy in children in South Africa\u2014the IeDEA Southern Africa collaboration","volume":"56","author":"MA Davies","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 3","key":"ref2","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1086\/521116","article-title":"Challenges to pediatric HIV care and treatment in South Africa","volume":"196","author":"T Meyers","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"ref3","first-page":"58","article-title":"Psychosocial functioning of children with AIDS and HIV infection: review of the literature from a socioecological framework","volume":"28","author":"RG Steele","year":"2007","journal-title":"J Dev Behav Pediatr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.7448\/IAS.16.1.18579","article-title":"Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents","volume":"16","author":"AL Agwu","year":"2013","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11904-009-0026-8","article-title":"Pediatric adherence to HIV antiretroviral therapy","volume":"6","author":"J Haberer","year":"2009","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref6","unstructured":"National Consolidatd Guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. National Department of Health, South Africa, 2015."},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1074\/jbc.M308806200","article-title":"Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations","volume":"279","author":"J Deval","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/QAI.0b013e3181bef889","article-title":"Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection","volume":"54","author":"M Opravil","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jmv.21085","article-title":"HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy","volume":"80","author":"N Gianotti","year":"2008","journal-title":"Journal Med Virol"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/AAC.47.2.747-754.2003","article-title":"Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation","volume":"47","author":"Y Quan","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/01.aids.0000218542.08845.b2","article-title":"Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)","volume":"20","author":"A Castagna","year":"2006","journal-title":"AIDS"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jmv.2023","article-title":"Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations","volume":"65","author":"HL Devereux","year":"2001","journal-title":"J Med Virol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcv.2009.12.007","article-title":"Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial","volume":"47","author":"A Soria","year":"2010","journal-title":"J Clin Virol"},{"issue":"10","key":"ref14","article-title":"Lamivudine Monotherapy as a Holding Strategy in HIV-Infected Children in South Africa","volume":"4","author":"OK Lazarus EM","journal-title":"J AIDS Clin Res"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1097\/INF.0000000000001156","article-title":"Lamivudine Monotherapy: Experience of Medium-term Outcomes in HIV-infected Children Unable to Adhere to Triple Therapy","volume":"35","author":"V Linder","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"19763","DOI":"10.7448\/IAS.17.4.19763","article-title":"Lamivudine monotherapy as a safe option for HIV-infected paediatric clients with adherence challenges: new evidence from a large South African cohort","volume":"17","author":"V Linder","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"ref17","unstructured":"Rabie H, Essack G, Cotton M, editors. Monotherapy with lamivudine in HIV-infected children: the experience at Tygerberg hospital. South African HIV Clinicians Society Conference; 2012 25\u201328 November 2012; Cape Town, South Africa."},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/ije\/dyr080","article-title":"Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa","volume":"41","author":"M Egger","year":"2012","journal-title":"Int J Epidemiol"},{"key":"ref19","unstructured":"National Antiretroviral Treatment Guidelines. In: National Department of Health SA, editor.: Jacana; 2004."},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0b013e3181642257","article-title":"Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis","volume":"47","author":"Y Ren","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/QAD.0b013e3282f2be1d","article-title":"Pharmacokinetics, safety and efficacy of lopinavir\/ritonavir in infants less than 6 months of age: 24 week results","volume":"22","author":"EG Chadwick","year":"2008","journal-title":"AIDS"},{"key":"ref22","unstructured":"WHO. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Switzerland: 2006."},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"20936","DOI":"10.7448\/IAS.19.1.20936","article-title":"Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA","volume":"19","author":"N Rakhmanina","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"ref24","article-title":"3TC\/FTC monotherapy vs. continuing failing cART as a bridging ART strategy in persistently nonadherent HIV-infected youth with M184V resistance: results of IMPAACT P1094","author":"A Agwu","year":"2014","journal-title":"6th International Workshop on HIV Pediatrics"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/QAD.0000000000000809","article-title":"CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States","volume":"29","author":"L Fairlie","year":"2015","journal-title":"AIDS"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/INF.0000000000001481","article-title":"econd- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review","volume":"36","author":"E Lazarus","year":"2017","journal-title":"Pediatr Infect Dis J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0205455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:47:07Z","timestamp":1589021227000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0205455"}},"subtitle":[],"editor":[{"given":"Justyna Dominika","family":"Kowalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0205455","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]}}}